miR-42 as A Drug and Biomarker Target for Human Diseases (G442247)

Target Name: RFPL4B

NCBI ID: G442247

RFPL4B

miR-42 as A Drug and Biomarker Target for Human Diseases

The research field of RNA-protein interactions (RNA-protein) has seen a tremendous growth in recent years due to the increasing power of sequencing technologies and the availability of various RNA sources. One of the RNA sources that has gained significant attention is microRNA (miRNA), which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation. miRAs have been shown to play important roles in various biological processes, including development, growth, and metabolism, and are involved in the regulation of cellular pathways that are critical for human health and disease.

One of the well-known miRAs is human microRNA-42 (miR-42), also known as RFPLB_HUMAN. miR-42 is a 21-nt RNA molecule that plays a role in the regulation of various cellular pathways, including cell growth, apoptosis, and inflammation. The function of miR-42 is still not well understood, but its potential as a drug target or biomarker makes it an attractive target for researchers to investigate.

Drug Target Potential

The drug targeting of miRAs is an attractive approach for the development of new therapeutic agents for various diseases. miRAs have been shown to play important roles in the regulation of cellular pathways that are critical for human health and disease, making them an attractive target for drug development. The target of miR-42 is the human protein heat shock protein 70 (HSP70), which is a key regulator of various cellular pathways, including cell growth, apoptosis, and inflammation.

HSP70 is a protein that plays a critical role in the regulation of heat shock responses, which are critical for the survival of cells under extreme temperatures, such as those that occur during exercise or exposure to environmental stressors. HSP70 functions as a chaperone, which helps to recruit other proteins to the site of stress and ensures the efficient regulation of cellular processes that are critical for the maintenance of cellular homeostasis.

Studies have shown that miR-42 can interact with HSP70 and that this interaction plays a role in the regulation of various cellular pathways, including cell growth, apoptosis, and inflammation. miR-42 has been shown to physically interact with HSP70 using its 5'-end, which allows it to bind to the protein. The binding of miR-42 to HSP70 has been shown to regulate the expression of various genes that are involved in cell growth, apoptosis, and inflammation.

In addition, miR-42 has also been shown to regulate the stability of HSP70, which is critical for the regulation of cellular processes that are critical for the maintenance of cellular homeostasis. The regulation of HSP70 stability by miR-42 has been shown to play a role in the regulation of cellular pathways that are critical for the survival of cells under extreme temperatures, such as those that occur during exercise or exposure to environmental stressors.

Biomarker Potential

The potential use of miRAs as biomarkers has been shown to be an attractive approach for the diagnosis and treatment of various diseases. miRAs have been shown to play important roles in the regulation of various cellular pathways, including cell growth, apoptosis, and inflammation. As such, they have the potential to serve as biomarkers for a variety of diseases, including cancer, cardiovascular disease, and neurodegenerative diseases.

Studies have shown that miR-42 can be used as a biomarker for various diseases, including cancer. For example, miR-42 has been shown to be regulated in various types of cancer, including breast, lung, and colon cancer. The regulation of miR-42 has been shown to play a role in the development and progression of these diseases, making it an attractive target for the development of new therapeutic agents for cancer.

In addition, miR-42 has also been shown to be regulated in various cardiovascular diseases, including heart failure and hypertension. The regulation

Protein Name: Ret Finger Protein Like 4B

The "RFPL4B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RFPL4B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets